Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mann Group
Danbury, Connecticut, United States
- Ownership
- Private
- Employees
- ~233
- Development stage
- Other
01
Overview
MannKind Corporation’s lead product, Afrezza (inhaled insulin), is FDA-approved and commercially available for diabetes. Afrezza is a rapid-acting insulin that peaks 12–15 minutes after inhalation and clears the body in 2–3 hours, delivered via a breath-powered inhaler and pre-metered cartridges[1]. The company has explored Technosphere-based formulations for other therapeutic proteins, but Afrezza remains its only approved drug. Clinical results for Afrezza have demonstrated rapid pharmacokinetics, but commercial uptake has been modest[1].
- Therapeutic areas
- CardiovascularEndocrinology
- Modalities
- Inhalable insulinprotein-based therapeutics
- Industry
- Biotech
02
Partnerships
Sanofi (past global licensing agreement for Afrezza, terminated 2016)[1]Immix Biopharma (collaboration on inhalable treatment for acute respiratory distress syndrome)[1]
Beyond the preview
Go deeper on Mann Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mann Group.